Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail

Fred Andersen, Torgeir A Engstad, Bjørn Straume, Matti Viitanen, Dag S Halvorsen, Samuel Hykkerud, Kjell Sjøbrend, Fred Andersen, Torgeir A Engstad, Bjørn Straume, Matti Viitanen, Dag S Halvorsen, Samuel Hykkerud, Kjell Sjøbrend

Abstract

Background: In Alzheimer's disease (AD) research patients are usually recruited from clinical practice, memory clinics or nursing homes. Lack of standardised inclusion and diagnostic criteria is a major concern in current AD studies. The aim of the study was to explore whether patient characteristics differ between study samples recruited from general practice and from a population based screening by mail within the same geographic areas in rural Northern Norway.

Methods: An interventional study in nine municipalities with 70000 inhabitants was designed. Patients were recruited from general practice or by population based screening of cognitive function by mail. We sent a questionnaire to 11807 individuals > or = 65 years of age of whom 3767 responded. Among these, 438 individuals whose answers raised a suspicion of cognitive impairment were invited to an extended cognitive and clinical examination. Descriptive statistics, chi-square, independent sample t-test and analyses of covariance adjusted for possible confounders were used.

Results: The final study samples included 100 patients recruited by screening and 87 from general practice. Screening through mail recruited younger and more self-reliant male patients with a higher MMSE sum score, whereas older women with more severe cognitive impairment were recruited from general practice. Adjustment for age did not alter the statistically significant differences of cognitive function, self-reliance and gender distribution between patients recruited by screening and from general practice.

Conclusions: Different recruitment procedures of individuals with cognitive impairment provided study samples with different demographic characteristics. Initial cognitive screening by mail, preceding extended cognitive testing and clinical examination may be a suitable recruitment strategy in studies of early stage AD. CLINICAL REGISTRATION: ClinicalTrial.gov Identifier: NCT00443014.

Figures

Figure 1
Figure 1
Flowchart of population based recruitment to the study by postal screening of cognitive function followed by clinical examination and testing. *Selection according to a predefined algorithm, Appendix 1. ** Mild cognitive impairment.

References

    1. Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15(4):463–471. doi: 10.1016/j.euroneuro.2005.04.003.
    1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262(18):2551–2556. doi: 10.1001/jama.262.18.2551.
    1. EU Commission. News Alert. Commission steps up action on Alzheimer's disease and other neurodegenerative conditions. 2009.
    1. Fitzpatrick AL, Fried LP, Williamson J, Crowley P, Posey D, Kwong L, Bonk J, Moyer R, Chabot J, Kidoguchi L, Furberg CD, Dekosky ST. Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience. Contemp Clin Trials. 2006;27(6):541–553. doi: 10.1016/j.cct.2006.06.007.
    1. Izal M, Nuevo R, Montorio I, Perez-Rojo G. Method of recruitment and the scores of self-report measures: the example of worry in the elderly. Arch Gerontol Geriatr. 2009;48(1):45–49. doi: 10.1016/j.archger.2007.09.009.
    1. Hully SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing Clinical Research. 2007.
    1. Stephan BC, Matthews FE, McKeith IG, Bond J, Brayne C. Early cognitive change in the general population: how do different definitions work? J Am Geriatr Soc. 2007;55(10):1534–1540. doi: 10.1111/j.1532-5415.2007.01386.x.
    1. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337(23):1667–1674. doi: 10.1056/NEJM199712043372306.
    1. Mahieux F, Onen F, Berr C, Volteau M, Habert MO, Legrain S, Dubois B. Early detection of patients in the pre demented stage of Alzheimer's disease: the Pre-Al Study. J Nutr Health Aging. 2009;13(1):21–26. doi: 10.1007/s12603-009-0004-2.
    1. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–746. doi: 10.1016/S1474-4422(07)70178-3.
    1. Lolk A, Nielsen H, Andersen K, Andersen J, Kragh-Sorensen P. CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive Examination. Acta Psychiatr Scand. 2000;102(5):331–335. doi: 10.1034/j.1600-0447.2000.102005331.x.
    1. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998;53(1):S9–16.
    1. van Uffelen JG, Chin APM, Klein M, van Mechelen MW, Hopman-Rock M. Detection of memory impairment in the general population: screening by questionnaire and telephone compared to subsequent face-to-face assessment. Int J Geriatr Psychiatry. 2007;22(3):203–210. doi: 10.1002/gps.1661.
    1. Palmer K, Bäckman L, Winblad B, Fratiglioni L. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease. Int Psychogeriatr. 2008;20(2):252–258. doi: 10.1017/S1041610207006564.
    1. Palmer K, Bäckman L, Winblad B, Fratiglioni L. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ. 2003;326(7383):245. doi: 10.1136/bmj.326.7383.245.
    1. The Norwegian Competence Centre Aging and Health inventor. Dementia diagnosing tools. 2009.
    1. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19(4):1015–1022. doi: 10.1017/S0033291700005742.
    1. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, Grafman JH. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37(8):725–729.
    1. Dratcu L, da Costa RL, Calil HM. Depression assessment in Brazil. The first application of the Montgomery-Asberg Depression Rating Scale. Br J Psychiatry. 1987;150:797–800. doi: 10.1192/bjp.150.6.797.
    1. Bebbington P. Welcome to ICD-10. Soc Psychiatry Psychiatr Epidemiol. 1992;27(6):255–257.
    1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944.
    1. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment-- beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240–246. doi: 10.1111/j.1365-2796.2004.01380.x.
    1. SSB. Norwegian Statistics. 2008.
    1. Bernhardt T, Seidler A, Frölich L. The effect of psychosocial factors on risk of dementia. Fortschr Neurol Psychiatr. 2002;70(6):283–288. doi: 10.1055/s-2002-32023.
    1. Crews WD Jr, Harrison DW, Keiser AM, Kunze CM. The memory screening outreach program: findings from a large community-based sample of middle-aged and older adults. J Am Geriatr Soc. 2009;57(9):1697–1703. doi: 10.1111/j.1532-5415.2009.02404.x.
    1. Woods RT, Moniz-Cook E, Iliffe S, Campion P, Vernooij-Dassen M, Zanetti O, Franco M. Dementia: issues in early recognition and intervention in primary care. J R Soc Med. 2003;96(7):320–324. doi: 10.1258/jrsm.96.7.320.
    1. Vernooij-Dassen MJ, Moniz-Cook ED, Woods RT, De LJ, Leuschner A, Zanetti O, de Rotrou J, Kenny G, Franco M, Peters V, Iliffe S. Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma. Int J Geriatr Psychiatry. 2005;20(4):377–386. doi: 10.1002/gps.1302.
    1. Carter RE, Rose DA, Palesch YY, Mintzer JE. Alzheimer's Disease in the Family Practice Setting: Assessment of a Screening Tool. Prim Care Companion J Clin Psychiatry. 2004;6(6):234–238. doi: 10.4088/PCC.v06n0603.
    1. Wilcock J, Bryans M, Turner S, O'Carroll R, Keady J, Levin E. Methodological problems in dementia research in primary care: a case study of a randomized controlled trial. Primary Health Care Research and Development. 2006;7:1–10. doi: 10.1191/1463423606pc262ed.
    1. Engedal K. Diagnosis and treatment of dementia. Tidsskr Nor Laegeforen. 2002;122(5):520–524.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅